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without prior neuro-psychiatric history, as pointed out by the authors,
their results suggest that the pons might play a role in affective/mood
disorders. Depressive and related disorders are a category of mood
disorders in the Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-5). It is noteworthy that depression is encountered
in several neuro-degenerative diseases, such as Parkinson's disease
(PD). What do the ﬁndings of Lee et al. might mean for PD patients?
In PD, theponsdegenerates, encompassing serotonin (5-HT)-producing
raphe nuclei (Halliday et al., 1990). The role of 5-HT inmood and affect has
been well-documented (Berger et al., 2009). As many as 30–40% of PD pa-Affective processing determines how we react to stimuli, interact
with the surroundings and perceive theworld. It shapes our behaviour.
In their article in this issue of EBioMedicine, Lee et al. (Lee et al., 2015)
shed light on the involvement of the pons in affective processing in
healthy volunteers.
The authors report the ﬁndings of experiments where they showed
images to adult women. The images consisted of visual stimuli contain-
ing a positive, neutral or negative affective charge. They conducted
blood-oxygen-level dependent (BOLD) contrast functional magnetic
resonance imaging (fMRI) to determine brain metabolism during the
visualising and subsequent emotional processes. Speciﬁcally, they
analysed task-based BOLD signals, tested small-world connectivity
and examined resting-state functional and diffusion tensor imaging
(DTI) structural connectivity.
They discovered that showing positive visual stimuli results in
activation of a pontine region, possibly the caudal raphe nuclei. A signif-
icant functional connectivity was found between the pons and cortico-
sub-cortical structures involved in affective processing, encompassing
the caudate nucleus, thalamus, hippocampus, amygdala, as well as the
cingulate, insular and frontal cortices. The authors conclude that
their ﬁndings indicate that the pons forms a network with
“cortico-limbic-striatal” systems to mediate one's affective state after
seeing emotionally-charged images.om.2015.10.020.
h Centre, R09.436, 900 St. Denis
. This is an open access article undertients are afﬂicted by depressive symptoms (Aarsland et al., 2009). Tallying
this to the results of Lee et al., it becomes plausible that dysfunctional pon-
tine structures might play a role in mood disorders in PD.
Several in vivo imaging studies have examined the raphe 5-HT
transporter in PD, via either positron emission tomography (PET) or
single-photon emission computed tomography (SPECT) modalities.
However, as these PET and SPECT studies were designed to study the
5-HT transporter function, theywould, atmost, provide only indirect as-
sessment of the pons per se. Moreover, several of these were conducted
in non-depressed patients (Guttman et al., 2007; Politis et al., 2010a) or
focussed on other regions of interest, e.g. the midbrain (Haapaniemi
et al., 2001; Berding et al., 2003).
Two studies are worth discussing here, as they assessed the 5-HT
transporter binding in the caudal raphe nuclei, which are located in
the pons. In a recent SPECT study encompassing 345 early, drug-
naïve male and female PD patients, therewas no correlation between
raphe (rostral and caudal) 5-HT transporter binding and depression
(Qamhawi et al., 2015). In contrast, in a PET study encompassing PD
patients with and without depression and healthy controls, caudal
raphe nuclei 5-HT transporter binding was lower in non-depressed
PD patients when compared to depressed PD patients and healthy
controls, while no difference was encountered between depressed
PD patients and controls (Politis et al., 2010b). It should be noted
that the PD patients from this last study were more advanced than
those from the ﬁrst study and were not drug-naïve, thus making
the PD populations from the two studies difﬁcult to compare. The
fate of 5-HT transporter located in the caudal raphe nuclei therefore
appears unclear in PD and possibly varies according to disease pro-
gression and medication intake. Nevertheless, the second study
suggests that 5-HT transporter binding is higher in depressed PDthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1593P. Huot / EBioMedicine 2 (2015) 1592–1593patients compared to depressed patients; how does that relate to the
increased metabolic activity found by Lee et al. in the pons in their
study needs to be further investigated.
In summary, Lee et al.'s results point out that the pons might be
involved in affective processing of visual stimuli. Their study reﬁnes
the understanding of affective processing and has implications to better
understand the networks underlying affective processing in the physio-
logical state. It also provides a newneuro-anatomical substrate to inves-
tigate in neuro-degenerative conditionswhere there are affective/mood
disorders such as PD.
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